Operating Expenses Summary of ResMed Inc.

ResMed Inc.'s latest annual operating expenses in 2024 was 1.36 Billion USD , up 10.95% from previous year.
ResMed Inc.'s latest quarterly operating expenses in 2024 FY was 1.22 Billion USD , up 1.74% from previous quarter.
ResMed Inc. reported a annual operating expenses of 1.2 Billion USD in annual operating expenses 2023, up 17.54% from previous year.
ResMed Inc. reported a annual operating expenses of 1.02 Billion USD in annual operating expenses 2022, up 10.5% from previous year.
ResMed Inc. reported a quarterly operating expenses of 323.04 Million USD for 2024 Q4, up 5.23% from previous quarter.
ResMed Inc. reported a quarterly operating expenses of 1.22 Billion USD for 2024 FY, up 1.74% from previous quarter.

Annual Operating Expenses Chart of ResMed Inc. (2024 - 1993)

Historical Annual Operating Expenses of ResMed Inc. (2024 - 1993)

Year	Operating Expenses	Operating Expenses Growth
2024	1.36 Billion USD	10.95%
2023	1.2 Billion USD	17.54%
2022	1.02 Billion USD	10.5%
2021	926.74 Million USD	1.98%
2020	908.72 Million USD	0.9%
2019	900.59 Million USD	12.31%
2018	801.9 Million USD	7.64%
2017	745.01 Million USD	19.17%
2016	625.16 Million USD	4.87%
2015	596.16 Million USD	3.08%
2014	578.37 Million USD	-1.27%
2013	585.83 Million USD	11.52%
2012	525.32 Million USD	10.97%
2011	473.4 Million USD	14.88%
2010	412.1 Million USD	14.48%
2009	359.99 Million USD	3.33%
2008	348.4 Million USD	18.37%
2007	294.32 Million USD	20.39%
2006	244.47 Million USD	46.31%
2005	167.08 Million USD	27.18%
2004	131.37 Million USD	24.12%
2003	105.84 Million USD	-42.49%
2002	184.05 Million USD	201.44%
2001	61.06 Million USD	18.03%
2000	51.73 Million USD	34.37%
1999	38.5 Million USD	29.19%
1998	29.8 Million USD	28.45%
1997	23.2 Million USD	52.63%
1996	15.2 Million USD	52.0%
1995	10 Million USD	49.25%
1994	6.7 Million USD	63.41%
1993	4.1 Million USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	307.61 Million USD	-1.11%
2024 Q4	323.04 Million USD	5.23%
2024 FY	1.22 Billion USD	1.74%
2024 Q3	306.99 Million USD	-0.2%
2024 Q1	311.06 Million USD	-6.07%
2023 FY	1.2 Billion USD	17.54%
2023 Q3	317.08 Million USD	8.92%
2023 Q4	331.15 Million USD	4.44%
2023 Q2	291.1 Million USD	9.82%
2023 Q1	265.07 Million USD	-0.76%
2022 Q1	244.37 Million USD	-1.88%
2022 Q3	256.93 Million USD	0.52%
2022 FY	1.02 Billion USD	10.5%
2022 Q4	267.11 Million USD	3.96%
2022 Q2	255.6 Million USD	4.6%
2021 FY	926.74 Million USD	1.98%
2021 Q4	249.05 Million USD	11.27%
2021 Q2	232.09 Million USD	4.66%
2021 Q1	221.76 Million USD	-1.93%
2021 Q3	223.83 Million USD	-3.56%
2020 Q3	232.16 Million USD	0.97%
2020 FY	908.72 Million USD	0.9%
2020 Q4	226.12 Million USD	-2.6%
2020 Q1	233.95 Million USD	-4.96%
2020 Q2	229.92 Million USD	-1.72%
2019 Q2	220.53 Million USD	10.84%
2019 FY	900.59 Million USD	12.31%
2019 Q4	246.17 Million USD	4.79%
2019 Q1	198.96 Million USD	-4.38%
2019 Q3	234.93 Million USD	6.53%
2018 Q4	208.07 Million USD	5.62%
2018 FY	801.9 Million USD	7.64%
2018 Q3	197 Million USD	-3.33%
2018 Q2	203.77 Million USD	5.56%
2018 Q1	193.04 Million USD	-1.71%
2017 Q2	189.18 Million USD	8.08%
2017 Q3	184.37 Million USD	-2.55%
2017 FY	745.01 Million USD	19.17%
2017 Q4	196.41 Million USD	6.53%
2017 Q1	175.03 Million USD	-3.26%
2016 Q2	151.61 Million USD	7.84%
2016 FY	625.16 Million USD	4.87%
2016 Q3	152.01 Million USD	0.26%
2016 Q4	180.93 Million USD	19.02%
2016 Q1	140.59 Million USD	-8.64%
2015 Q4	153.88 Million USD	5.72%
2015 Q3	145.56 Million USD	-5.53%
2015 Q1	142.63 Million USD	-8.83%
2015 FY	596.16 Million USD	3.08%
2015 Q2	154.07 Million USD	8.02%
2014 FY	578.37 Million USD	-1.27%
2014 Q4	156.44 Million USD	6.36%
2014 Q1	131.09 Million USD	-24.52%
2014 Q2	143.73 Million USD	9.64%
2014 Q3	147.09 Million USD	2.33%
2013 FY	585.83 Million USD	11.52%
2013 Q1	128.15 Million USD	-6.27%
2013 Q2	140.64 Million USD	9.74%
2013 Q4	173.68 Million USD	21.16%
2013 Q3	143.35 Million USD	1.93%
2012 Q3	132.94 Million USD	1.13%
2012 FY	525.32 Million USD	10.97%
2012 Q1	124.18 Million USD	-6.05%
2012 Q2	131.46 Million USD	5.86%
2012 Q4	136.73 Million USD	2.85%
2011 Q2	116.12 Million USD	8.98%
2011 Q3	341.22 Million USD	193.84%
2011 Q4	132.17 Million USD	-61.26%
2011 FY	473.4 Million USD	14.88%
2011 Q1	106.56 Million USD	-2.15%
2010 FY	412.1 Million USD	14.48%
2010 Q1	96.51 Million USD	0.21%
2010 Q2	105.28 Million USD	9.08%
2010 Q3	104.4 Million USD	-0.83%
2010 Q4	108.89 Million USD	4.3%
2009 Q3	86.42 Million USD	-1.45%
2009 Q2	87.69 Million USD	-3.17%
2009 Q4	96.3 Million USD	11.44%
2009 Q1	90.56 Million USD	-8.61%
2009 FY	359.99 Million USD	3.33%
2008 Q1	77.71 Million USD	-4.24%
2008 FY	348.4 Million USD	18.37%
2008 Q4	99.09 Million USD	13.76%
2008 Q3	87.1 Million USD	3.11%
2008 Q2	84.48 Million USD	8.7%
2007 Q1	65.98 Million USD	-0.66%
2007 Q2	71.06 Million USD	7.71%
2007 FY	294.32 Million USD	20.39%
2007 Q4	81.15 Million USD	6.61%
2007 Q3	76.12 Million USD	7.12%
2006 Q3	64.12 Million USD	8.16%
2006 Q4	66.41 Million USD	3.58%
2006 Q2	59.28 Million USD	8.48%
2006 Q1	54.65 Million USD	9.07%
2006 FY	244.47 Million USD	46.31%
2005 Q2	41.81 Million USD	24.87%
2005 Q1	33.48 Million USD	-4.56%
2005 FY	167.08 Million USD	27.18%
2005 Q4	50.1 Million USD	20.19%
2005 Q3	41.68 Million USD	-0.29%
2004 Q1	28.2 Million USD	-11.34%
2004 Q2	33.03 Million USD	17.11%
2004 FY	131.37 Million USD	24.12%
2004 Q4	35.08 Million USD	0.06%
2004 Q3	35.05 Million USD	6.14%
2003 Q2	25.76 Million USD	16.14%
2003 Q3	26.08 Million USD	1.22%
2003 Q4	31.81 Million USD	21.98%
2003 FY	105.84 Million USD	-42.49%
2003 Q1	22.18 Million USD	-82.51%
2002 FY	184.05 Million USD	201.44%
2002 Q3	21.2 Million USD	15.27%
2002 Q1	17.64 Million USD	-7.65%
2002 Q2	18.39 Million USD	4.22%
2002 Q4	126.82 Million USD	498.21%
2001 Q4	19.1 Million USD	14.11%
2001 FY	61.06 Million USD	18.03%
2001 Q3	16.74 Million USD	11.57%
2001 Q2	15 Million USD	7.63%
2001 Q1	13.94 Million USD	-0.73%
2000 Q2	12.5 Million USD	6.84%
2000 Q3	13.52 Million USD	8.18%
2000 Q4	14.04 Million USD	3.88%
2000 FY	51.73 Million USD	34.37%
2000 Q1	11.7 Million USD	9.35%
1999 Q1	8.8 Million USD	7.32%
1999 Q2	9.6 Million USD	9.09%
1999 Q3	9.2 Million USD	-4.17%
1999 Q4	10.7 Million USD	16.3%
1999 FY	38.5 Million USD	29.19%
1998 Q1	6.9 Million USD	4.55%
1998 Q3	7.8 Million USD	13.04%
1998 Q4	8.2 Million USD	5.13%
1998 FY	29.8 Million USD	28.45%
1998 Q2	6.9 Million USD	0.0%
1997 FY	23.2 Million USD	52.63%
1997 Q3	5.9 Million USD	5.36%
1997 Q4	6.6 Million USD	11.86%
1997 Q1	5.2 Million USD	4.0%
1997 Q2	5.6 Million USD	7.69%
1996 FY	15.2 Million USD	52.0%
1996 Q3	3.7 Million USD	0.0%
1996 Q4	5 Million USD	35.14%
1996 Q1	- USD	100.0%
1996 Q2	- USD	0.0%
1995 Q2	- USD	0.0%
1995 Q3	- USD	0.0%
1995 FY	10 Million USD	49.25%
1995 Q4	-20.7 Million USD	0.0%
1995 Q1	- USD	100.0%
1994 Q4	-12.6 Million USD	0.0%
1994 FY	6.7 Million USD	63.41%
1994 Q1	- USD	100.0%
1994 Q3	- USD	0.0%
1994 Q2	- USD	0.0%
1993 Q2	- USD	0.0%
1993 FY	4.1 Million USD	0.0%
1993 Q3	- USD	0.0%
1993 Q1	- USD	0.0%
1993 Q4	-7 Million USD	0.0%

Peer Operating Expenses Comparison of ResMed Inc.

Name	Operating Expenses	Operating Expenses Difference
Alcon Inc.	4.2 Billion USD	67.482%
AptarGroup, Inc.	814.37 Million USD	-68.027%
Baxter International Inc.	5.27 Billion USD	74.045%
Becton, Dickinson and Company	6.04 Billion USD	77.371%
Bausch + Lomb Corporation	2.37 Billion USD	42.36%
Haemonetics Corporation	526.66 Million USD	-159.818%
Envista Holdings Corp	1.15 Billion USD	-18.917%
Teleflex Incorporated	1.08 Billion USD	-26.208%
Warby Parker Inc.	437.22 Million USD	-212.971%
West Pharmaceutical Services, Inc.	454 Million USD	-201.404%

Global Stocks Search

ResMed Inc. (RMD)

Operating Expenses Summary of ResMed Inc.

Annual Operating Expenses Chart of ResMed Inc. (2024 - 1993)

Historical Annual Operating Expenses of ResMed Inc. (2024 - 1993)

Peer Operating Expenses Comparison of ResMed Inc.